- Home
- PTHL vs IAE Comparison
PTHL vs IAE Comparison
Compare PTHL & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTHL
- IAE
- Stock Information
- Founded
- PTHL 1998
- IAE 2007
- Country
- PTHL China
- IAE United States
- Employees
- PTHL N/A
- IAE N/A
- Industry
- PTHL
- IAE Trusts Except Educational Religious and Charitable
- Sector
- PTHL
- IAE Finance
- Exchange
- PTHL Nasdaq
- IAE Nasdaq
- Market Cap
- PTHL 85.4M
- IAE 74.3M
- IPO Year
- PTHL 2024
- IAE N/A
- Fundamental
- Price
- PTHL $29.15
- IAE $7.16
- Analyst Decision
- PTHL
- IAE
- Analyst Count
- PTHL 0
- IAE 0
- Target Price
- PTHL N/A
- IAE N/A
- AVG Volume (30 Days)
- PTHL 1.9M
- IAE 46.3K
- Earning Date
- PTHL 02-11-2025
- IAE 01-01-0001
- Dividend Yield
- PTHL N/A
- IAE 10.21%
- EPS Growth
- PTHL N/A
- IAE N/A
- EPS
- PTHL N/A
- IAE N/A
- Revenue
- PTHL $448,196.00
- IAE N/A
- Revenue This Year
- PTHL N/A
- IAE N/A
- Revenue Next Year
- PTHL N/A
- IAE N/A
- P/E Ratio
- PTHL N/A
- IAE N/A
- Revenue Growth
- PTHL N/A
- IAE N/A
- 52 Week Low
- PTHL $1.32
- IAE $5.31
- 52 Week High
- PTHL $30.79
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- PTHL N/A
- IAE 70.20
- Support Level
- PTHL N/A
- IAE $7.02
- Resistance Level
- PTHL N/A
- IAE $7.09
- Average True Range (ATR)
- PTHL 0.00
- IAE 0.06
- MACD
- PTHL 0.00
- IAE 0.01
- Stochastic Oscillator
- PTHL 0.00
- IAE 94.64
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.